特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
858180

創傷ケア:培養皮膚 (代用皮膚) 置換および活性創傷修復モジュレーター

Wound Care: Tissue-Engineered Skin Replacements and Active Wound Repair Modulators

出版日: | 発行: Datamonitor Healthcare | ページ情報: 英文 53 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
創傷ケア:培養皮膚 (代用皮膚) 置換および活性創傷修復モジュレーター
出版日: 2018年08月03日
発行: Datamonitor Healthcare
ページ情報: 英文 53 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、米国、EU主要5ヶ国、日本、およびRoW (その他地域) 市場における培養皮膚 (代用皮膚) 置換および活性創傷修復モジュレーターの製品、現在/将来の市場、競合企業、および機会について詳細に分析しています。

エグゼクティブサマリー

第1章 培養皮膚 (代用皮膚) 置換

  • 同種移植片
  • 自家移植片
  • 異種移植片
  • 自己移植および培養皮膚置換
  • 市場予測

第2章 活性創傷修復モジュレーター

  • 成長促進要因
  • 遺伝子療法エージェント
  • 幹細胞
  • その他の活性創傷修復モジュレーター・医薬品
  • 参考資料

付録:企業リスト

目次
Product Code: #MDT18011

OVERVIEW

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the US, 5EU, Japan, and RoW markets for tissue-engineered skin replacements (epidermal, dermal, and multilayer equivalents, and amniotic tissue grafts) and active wound repair modulators (growth factors, gene therapy agents, and stem cells).

KEY QUESTIONS ANSWERED:

  • What are the key drivers and limiters to the global wound care products market?
  • Which competitors are leading the market and introducing new technology?
  • How are technological advancements impacting market growth?
  • Which areas of the wound care products market are experiencing dynamic growth?
  • How are mergers and acquisitions affecting the markets shares of leading competitors?

WOUND CARE HIGHLIGHTS

  • The combined global market for tissue-engineered skin replacements and active wound repair modulators totaled more than $1bn in 2017, and is expected to climb at a rate of 6.0% over the next half-decade.
  • The tissue-engineered skin replacements segment accounts for nearly 90% of sales, with the 5EU markets, Japan, and the RoW markets combined accounting for the remaining 10% of sales.
  • The US accounts for nearly 92% of global sales in this market, due to factors including slower adoption of skin replacements in international markets as a result of cultural aversion to the use of cadaveric tissue, concerns regarding disease transmission, and limited reimbursement.

TABLE OF CONTENTS

Executive Summary

  • i. Tissue-engineered skin replacements
  • ii. Active wound repair modulators
  • iii. Market analysis
  • iv. Major competitors
  • v. Methodology
  • Exhibit ES-1: Tissue-engineered skin replacements and active wound repair modulators, market forecast ($m), 2017-22

1. Tissue-Engineered Skin Replacements

  • 1.1. Allografts
  • 1.2. Autografts
  • 1.3. Xenografts
  • 1.4. Autologous and tissue-engineered skin replacements
    • 1.4.1. Epidermal equivalent products
    • 1.4.2. Dermal equivalent products
    • 1.4.3. Multilayer equivalent products
    • 1.4.4. Amniotic tissue grafts
  • 1.5. Market forecast
  • 1.6. Competitive analysis
  • 1.7. Bibliography
  • Exhibit 1-1: Tissue-engineered skin replacements, market forecast, 2017-22
  • Exhibit 1-2: Tissue-engineered skin replacements market, share by supplier, 2017

2. Active Wound Repair Modulators

  • 2.1. Growth factors
    • 2.1.1. Growth factor classification
    • 2.1.2. Competitors and products
    • 2.1.3. Market forecast
  • 2.2. Gene therapy agents
  • 2.3. Stem cells
    • 2.3.1. Types of stem cells
    • 2.3.2. The role of stem cells in wound healing
  • 2.4. Other active wound repair modulators and pharmaceuticals
    • 2.4.1. Antibiotics and anti-infectives
    • 2.4.2. Hormones
    • 2.4.3. Matrix metalloproteinase enzyme inhibitors
    • 2.4.4. Neuropeptides in diabetic wounds
    • 2.4.5. Other products
  • 2.5. Bibliography
  • Exhibit 2-1: Selected growth factors under development for wound healing applications
  • Exhibit 2-2: The angiogenesis process
  • Exhibit 2-3: Growth factors, market forecast ($m), 2017-22

Appendix: Company Listing

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.